S&P 500   4,327.16 (+0.16%)
DOW   33,938.18 (-0.08%)
QQQ   358.57 (+0.18%)
AAPL   175.75 (+0.55%)
MSFT   315.96 (-0.33%)
META   299.47 (+0.13%)
GOOGL   130.78 (+0.41%)
AMZN   131.49 (+1.84%)
TSLA   245.52 (+0.26%)
NVDA   419.78 (+0.88%)
NIO   8.39 (-1.64%)
BABA   87.02 (-1.45%)
AMD   96.82 (+0.64%)
T   15.07 (-0.33%)
F   12.58 (+1.21%)
MU   68.11 (-1.12%)
CGC   0.93 (+11.05%)
GE   111.65 (+0.36%)
DIS   80.80 (-0.55%)
AMC   8.17 (+7.22%)
PFE   32.74 (+0.15%)
PYPL   58.74 (+1.49%)
NFLX   384.40 (+1.21%)
S&P 500   4,327.16 (+0.16%)
DOW   33,938.18 (-0.08%)
QQQ   358.57 (+0.18%)
AAPL   175.75 (+0.55%)
MSFT   315.96 (-0.33%)
META   299.47 (+0.13%)
GOOGL   130.78 (+0.41%)
AMZN   131.49 (+1.84%)
TSLA   245.52 (+0.26%)
NVDA   419.78 (+0.88%)
NIO   8.39 (-1.64%)
BABA   87.02 (-1.45%)
AMD   96.82 (+0.64%)
T   15.07 (-0.33%)
F   12.58 (+1.21%)
MU   68.11 (-1.12%)
CGC   0.93 (+11.05%)
GE   111.65 (+0.36%)
DIS   80.80 (-0.55%)
AMC   8.17 (+7.22%)
PFE   32.74 (+0.15%)
PYPL   58.74 (+1.49%)
NFLX   384.40 (+1.21%)
S&P 500   4,327.16 (+0.16%)
DOW   33,938.18 (-0.08%)
QQQ   358.57 (+0.18%)
AAPL   175.75 (+0.55%)
MSFT   315.96 (-0.33%)
META   299.47 (+0.13%)
GOOGL   130.78 (+0.41%)
AMZN   131.49 (+1.84%)
TSLA   245.52 (+0.26%)
NVDA   419.78 (+0.88%)
NIO   8.39 (-1.64%)
BABA   87.02 (-1.45%)
AMD   96.82 (+0.64%)
T   15.07 (-0.33%)
F   12.58 (+1.21%)
MU   68.11 (-1.12%)
CGC   0.93 (+11.05%)
GE   111.65 (+0.36%)
DIS   80.80 (-0.55%)
AMC   8.17 (+7.22%)
PFE   32.74 (+0.15%)
PYPL   58.74 (+1.49%)
NFLX   384.40 (+1.21%)
S&P 500   4,327.16 (+0.16%)
DOW   33,938.18 (-0.08%)
QQQ   358.57 (+0.18%)
AAPL   175.75 (+0.55%)
MSFT   315.96 (-0.33%)
META   299.47 (+0.13%)
GOOGL   130.78 (+0.41%)
AMZN   131.49 (+1.84%)
TSLA   245.52 (+0.26%)
NVDA   419.78 (+0.88%)
NIO   8.39 (-1.64%)
BABA   87.02 (-1.45%)
AMD   96.82 (+0.64%)
T   15.07 (-0.33%)
F   12.58 (+1.21%)
MU   68.11 (-1.12%)
CGC   0.93 (+11.05%)
GE   111.65 (+0.36%)
DIS   80.80 (-0.55%)
AMC   8.17 (+7.22%)
PFE   32.74 (+0.15%)
PYPL   58.74 (+1.49%)
NFLX   384.40 (+1.21%)
NYSE:A

Agilent Technologies (A) Stock Forecast, Price & News

$111.56
+0.15 (+0.13%)
(As of 02:33 PM ET)
Compare
Today's Range
$110.53
$111.85
50-Day Range
$109.74
$128.46
52-Week Range
$109.00
$160.26
Volume
429,694 shs
Average Volume
1.77 million shs
Market Capitalization
$32.64 billion
P/E Ratio
29.20
Dividend Yield
0.81%
Price Target
$148.12

Agilent Technologies MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
32.6% Upside
$148.12 Price Target
Short Interest
Healthy
1.39% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.74
Upright™ Environmental Score
News Sentiment
0.84mentions of Agilent Technologies in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$538,450 Sold Last Quarter
Proj. Earnings Growth
5.54%
From $5.42 to $5.72 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.23 out of 5 stars

Computer And Technology Sector

14th out of 584 stocks

Analytical Instruments Industry

1st out of 27 stocks


A stock logo

About Agilent Technologies (NYSE:A) Stock

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

A Price History

A Stock News Headlines

From Naval Flight Officer to CEO
First Female Founded, Publicly Traded, Space Company. Discover more
Agilent (A) Boosts Genomic Profiling With New Collaboration
Agilent Technologies (NYSE:A) Sees Strong Trading Volume
From Naval Flight Officer to CEO
First Female Founded, Publicly Traded, Space Company. Discover more
Agilent To Sell Resolution Bioscience To Exact Sciences For Undisclosed Sum
Illumina Appoints Jacob Thaysen As CEO
Illumina taps Agilent's Jacob Thaysen as CEO
UPDATE 3-Illumina taps Agilent's Jacob Thaysen as CEO
See More Headlines
Receive A Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.

A Company Calendar

Ex-Dividend for 7/26 Dividend
6/30/2023
Dividend Payable
7/26/2023
Last Earnings
8/15/2023
Today
9/25/2023
Ex-Dividend for 10/25 Dividend
10/02/2023
Dividend Payable
10/25/2023
Fiscal Year End
10/31/2023
Next Earnings (Estimated)
11/20/2023

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
CUSIP
00846U10
Employees
18,100
Year Founded
1999

Price Target and Rating

Average Stock Price Forecast
$148.12
High Stock Price Forecast
$170.00
Low Stock Price Forecast
$110.00
Forecasted Upside/Downside
+32.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
15 Analysts

Profitability

Net Income
$1.25 billion
Pretax Margin
19.65%

Debt

Sales & Book Value

Annual Sales
$6.85 billion
Cash Flow
$6.37 per share
Book Value
$17.92 per share

Miscellaneous

Free Float
N/A
Market Cap
$32.63 billion
Optionable
Optionable
Beta
1.03

Social Links

10 Best Stocks to Own in 2023 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Michael R. McMullenMr. Michael R. McMullen (Age 62)
    CEO, Pres & Director
    Comp: $3.66M
  • Mr. Robert W. McMahon (Age 54)
    Sr. VP & CFO
    Comp: $1.54M
  • Mr. Henrik Ancher-JensenMr. Henrik Ancher-Jensen (Age 58)
    Sr. VP and Pres of Order Fulfillment & Supply Chain
    Comp: $1.31M
  • Mr. Samraat S. RahaMr. Samraat S. Raha (Age 50)
    Sr. VP and Pres of Diagnostics & Genomics Group
    Comp: $1.14M
  • Mr. Rodney GonsalvesMr. Rodney Gonsalves (Age 57)
    Principal Accounting Officer, VP & Corp. Controller
  • Mr. John Kohl
    Sr. VP & Chief Information Officer
  • Mr. Michael TangMr. Michael Tang (Age 49)
    Sr. VP, Gen. Counsel & Sec.
  • Mr. Dominique P. GrauMr. Dominique P. Grau (Age 64)
    Sr. VP of HR & Global Communications
  • Ms. Allison Ballmer
    Sr. VP of Strategy & Corp. Devel.
  • Ms. Yvonne Mackie
    MD of UK & Ireland Operations and VP of HR - Europe













A Stock - Frequently Asked Questions

Should I buy or sell Agilent Technologies stock right now?

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 1 sell rating, 3 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" A shares.
View A analyst ratings
or view top-rated stocks.

What is Agilent Technologies' stock price forecast for 2023?

15 Wall Street research analysts have issued 1-year target prices for Agilent Technologies' stock. Their A share price forecasts range from $110.00 to $170.00. On average, they predict the company's stock price to reach $148.12 in the next twelve months. This suggests a possible upside of 32.9% from the stock's current price.
View analysts price targets for A
or view top-rated stocks among Wall Street analysts.

How have A shares performed in 2023?

Agilent Technologies' stock was trading at $149.65 on January 1st, 2023. Since then, A shares have decreased by 25.6% and is now trading at $111.41.
View the best growth stocks for 2023 here
.

Are investors shorting Agilent Technologies?

Agilent Technologies saw a decline in short interest in August. As of August 31st, there was short interest totaling 4,040,000 shares, a decline of 10.4% from the August 15th total of 4,510,000 shares. Based on an average daily trading volume, of 1,930,000 shares, the days-to-cover ratio is presently 2.1 days. Currently, 1.4% of the shares of the company are sold short.
View Agilent Technologies' Short Interest
.

When is Agilent Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 20th 2023.
View our A earnings forecast
.

How were Agilent Technologies' earnings last quarter?

Agilent Technologies, Inc. (NYSE:A) posted its quarterly earnings results on Tuesday, August, 15th. The medical research company reported $1.43 EPS for the quarter, beating analysts' consensus estimates of $1.36 by $0.07. The medical research company earned $1.67 billion during the quarter, compared to the consensus estimate of $1.66 billion. Agilent Technologies had a trailing twelve-month return on equity of 29.86% and a net margin of 16.20%. The company's revenue was down 2.7% compared to the same quarter last year. During the same period last year, the firm posted $1.34 EPS.
Read the conference call transcript
.

How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?

Agilent Technologies declared a quarterly dividend on Wednesday, September 20th. Investors of record on Tuesday, October 3rd will be given a dividend of $0.225 per share on Wednesday, October 25th. This represents a $0.90 dividend on an annualized basis and a yield of 0.81%. The ex-dividend date is Monday, October 2nd.
Read our dividend analysis for A
.

Is Agilent Technologies a good dividend stock?

Agilent Technologies (NYSE:A) pays an annual dividend of $0.90 per share and currently has a dividend yield of 0.81%. The company has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 23.56%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, A will have a dividend payout ratio of 15.73% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for A.

How will Agilent Technologies' stock buyback program work?

Agilent Technologies declared that its Board of Directors has initiated a stock repurchase program on Monday, January 9th 2023, which allows the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to reacquire up to 4.4% of its stock through open market purchases. Stock buyback programs are typically an indication that the company's leadership believes its shares are undervalued.

What guidance has Agilent Technologies issued on next quarter's earnings?

Agilent Technologies issued an update on its fourth quarter 2023 earnings guidance on Tuesday, August, 22nd. The company provided earnings per share guidance of $1.33-$1.36 for the period, compared to the consensus earnings per share estimate of $1.35. The company issued revenue guidance of $1.66 billion-$1.71 billion, compared to the consensus revenue estimate of $1.69 billion.

What is Mike McMullen's approval rating as Agilent Technologies' CEO?

452 employees have rated Agilent Technologies Chief Executive Officer Mike McMullen on Glassdoor.com. Mike McMullen has an approval rating of 98% among the company's employees. This puts Mike McMullen in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Agilent Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), Boeing (BA) and Skyworks Solutions (SWKS).

What is Agilent Technologies' stock symbol?

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Who are Agilent Technologies' major shareholders?

Agilent Technologies' stock is owned by many different institutional and retail investors. Top institutional shareholders include Bank Julius Baer & Co. Ltd Zurich (12.72%), BlackRock Inc. (10.78%), State Street Corp (4.47%), Geode Capital Management LLC (2.16%), Northern Trust Corp (1.30%) and Cantillon Capital Management LLC (1.27%). Insiders that own company stock include Boon Hwee Koh, Dominique Grau, Henrik Ancher-Jensen, Jacob Thaysen, Michael R Mcmullen, Michael Tang, Padraig Mcdonnell, Rodney Gonsalves and Samraat S Raha.
View institutional ownership trends
.

How do I buy shares of Agilent Technologies?

Shares of A stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Agilent Technologies' stock price today?

One share of A stock can currently be purchased for approximately $111.41.

How much money does Agilent Technologies make?

Agilent Technologies (NYSE:A) has a market capitalization of $32.60 billion and generates $6.85 billion in revenue each year. The medical research company earns $1.25 billion in net income (profit) each year or $3.82 on an earnings per share basis.

How many employees does Agilent Technologies have?

The company employs 18,100 workers across the globe.

Does Agilent Technologies have any subsidiaries?
The following companies are subsidiares of Agilent Technologies: ACEA BIO, ATN Microwave, Accelicon Technologies, Acqiris, Advanced Analytical Technologies, Agilent Raman Spectroscopy, Agilent Technologies Luxco S.à.r.l., Agilent Technologies Luxembourg Holding S.à.r.l., Agilent Technologies Singapore (Global) Pte Ltd., Agilent Technologies Singapore (Holding) Pte. Ltd., Agilent Technologies Singapore (International) Pte. Ltd., Agilent Technologies World Trade Inc., Agilent's Interoperability Certification Labs, American Holographic, Aurora SFC Systems, BIOCIUS Life Sciences, BioTek Instruments, BioTek Instruments LLC, Biosystem Development, Cartagenia, Computational Biology, Dako Denmark, Dako Denmark ApS, Escort Instruments, Genohm, Gradient Design Automation, Halo Genomics, J&W Scientific, Lab901, LaserGen, Lionheart Technologies LLC, Luxcel Biosciensces Ltd., MTS Nano Instruments, MV Technology, Molecular Imaging Corp., Multiplicom, Novelx, Objective Systems Integrators, PXIT, ProZyme Inc, Qosnetics, RVM Scientific, RedSwitch, Resolution Bioscience, SAFCO, Seahorse Bioscience, Silicon Genetics, Stratagene, SynPro, TILL Photonics, ULTRA Scientific, Varian, Velocity11, Wavefront Research, Xpedion Design Systems, Young In Scientific Co. Ltd, Zymed, and iLab Solutions.
Read More
How can I contact Agilent Technologies?

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The official website for the company is www.agilent.com. The medical research company can be reached via phone at (800) 227-9770, via email at investor_relations@agilent.com, or via fax at 408-345-8474.

This page (NYSE:A) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -